Lawrence Brass is a notable inventor based in Bala Cynwyd, PA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of thrombin receptor activation. With a total of 2 patents, his work has implications for diagnosing and treating thrombotic disorders.

Latest Patents

Brass's latest patents include a method and kit for the detection of thrombin receptor activation. This method focuses on detecting thrombin-induced cell activation through a detection system capable of identifying the presence of the cleaved peptide fragment of the thrombin receptor. These methods are crucial for diagnosing and treating pre-thrombotic states or thrombotic disorders in patients. Another significant patent is the thrombin receptor activation assay, which determines thrombin receptor activation in a cell by measuring the internalization of a labeled antibody-thrombin receptor complex after exposure to an agonist peptide. This method is particularly useful in identifying thrombin receptor antagonists.

Career Highlights

Lawrence Brass is affiliated with the University of Pennsylvania, where he continues to advance research in his field. His innovative approaches have garnered attention and respect within the scientific community.

Collaborations

Brass has collaborated with esteemed colleagues such as James A. Hoxie and Ram Ramachandran, further enhancing the impact of his research.

Conclusion

Lawrence Brass's contributions to the field of thrombin receptor activation detection exemplify the importance of innovation in medical diagnostics. His work not only advances scientific understanding but also has the potential to improve patient outcomes in thrombotic disorders.